Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Growth |
| Morningstar category | Foreign Large Growth |
| Launch date | 01 May 2015 |
| Price currency | USD |
| Domicile | United States |
| Symbol | MXHTX |
| Manager & start date | John Remmert 27 Apr 2018 Thomas Murray 27 Apr 2018 Shane Duffy 27 Apr 2018 Donald Huber 27 Apr 2018 James Andrew 28 Apr 2023 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 490.26m USD As of Apr 30 2024 |
| Share class size | 471.49m USD As of Apr 30 2024 |
| Net expense ratio | 0.85% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 0.00 USD |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 18.81% | 13.99% | 0.00% | 13.99% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| ASML Holding NV ASML:AEX | +29.68% | 4.46% | |
| Nestle SA NESN:SWX | -11.44% | 2.96% | |
| Novo Nordisk A/S NOVO B:CPH | +66.15% | 2.73% | |
| LVMH Moet Hennessy Louis Vuitton SE MC:PAR | -9.71% | 1.95% | |
| Genmab A/S GMAB:CPH | -28.92% | 1.89% | |
| Per cent of portfolio in top 5 holdings: 13.99% |
Asset type
| Non-US stock | 94.10% |
| US stock | 4.57% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Cash | -0.01% |
| Other | 1.33% |
Top 5 sectors
| Healthcare | 18.91% |
| Technology | 18.76% |
| Industrials | 14.72% |
| Consumer Cyclical | 10.17% |
| Financial Services | 8.42% |
| Other | 18.63% |
Top 5 regions
| Eurozone | 30.05% |
| Europe - ex Euro | 21.45% |
| Japan | 15.99% |
| United Kingdom | 11.47% |
| Australasia | 4.84% |
| Other | 14.86% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
